NCT02945436 (Swerve) is a NA clinical trial of Substance Use Brief Intervention in HIV, sponsored by University of Michigan.

Who is sponsoring NCT02945436?

NCT02945436 is sponsored by University of Michigan.

What drugs are being tested in NCT02945436?

Interventions in NCT02945436: Substance Use Brief Intervention, Standard of Care (SOC).

What condition does NCT02945436 study?

NCT02945436 studies HIV, Substance Use.

Is NCT02945436 still recruiting?

NCT02945436 is currently completed. Last updated 6 July 2022.

Last reviewed 2022-07-06 · How we verify

NCT02945436: Swerve

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention

Completed NA Last updated 6 July 2022

What this trial tests

NA trial testing Substance Use Brief Intervention in HIV in 258 participants. Completed in 1 June 2021.

Timeline

7 April 2017

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	prevention
Enrollment	258
Start date	7 April 2017
Primary completion	1 June 2021
Estimated completion	1 June 2021
Sites	1 location across United States

Drugs / interventions tested

Substance Use Brief Intervention
Standard of Care (SOC) — full drug profile →

Conditions studied

HIV — all drugs for HIV →
Substance Use — all drugs for Substance Use →

Sponsor

University of Michigan

Who can join

Adults 15 to 29, any sex, with HIV or Substance Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A sample of 300 young (15-29) men who have sex with men (MSM) and transgender persons living in South-East Michigan's Detroit Metro Area (DMA) will be recruited through venue-based sampling and online ads to examine the efficacy of adding a substance use brief intervention (SUBI) to standard HIV prevention and care (SOC) for achieving gains in successful engagement in HIV care. The investigators will partner with Detroit-area AIDS Service Organizations (ASOs) to deliver the intervention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Comparing Social Media and In-Person Recruitment: Lessons Learned From Recruiting Substance-Using, Sexual and Gender Minority Adolescents and Young Adults for a Randomized Control Trial.
Parker JN, Hunter AS, Bauermeister JA, Bonar EE, et al · · 2021 · cited 32× · PMID 34855613 · DOI 10.2196/31657
HIV and Sexually Transmitted Infection Testing Among Substance-Using Sexual and Gender Minority Adolescents and Young Adults: Baseline Survey of a Randomized Controlled Trial.
Parker JN, Choi SK, Bauermeister JA, Bonar EE, et al · · 2022 · cited 5× · PMID 35776441 · DOI 10.2196/30944
Intervention to Increase HIV Testing Among Substance-Using Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.
Stephenson R, Bonar EE, Carrico A, Hunter A, et al · · 2018 · cited 3× · PMID 29712625 · DOI 10.2196/resprot.9414

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02945436 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 6 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02945436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing